Age-dependent acquisition of pathogenicity by SARS-CoV-2 Omicron BA.5
Brian Imbiakha, Shahrzad Ezzatpour, David W. Buchholz, Julie Sahler, Chengjin Ye, Ximena A. Olarte‐Castillo, Anna Zou, Cole Kwas, K. O'Hare, Annette Choi, Richard Adeleke, Solomiia Khomandiak, Laura B. Goodman, Mason Jager, Gary R. Whittaker, Luis Martínez‐Sobrido, Avery August, Hector C. Aguilar
Abstract
Pathology studies of SARS-CoV-2 Omicron variants of concern (VOC) are challenged by the lack of pathogenic animal models. While Omicron BA.1 and BA.2 replicate in K18-hACE2 transgenic mice, they cause minimal to negligible morbidity and mortality, and less is known about more recent Omicron VOC. Here, we show that in contrast to Omicron BA.1, BA.5-infected mice exhibited high levels of morbidity and mortality, correlating with higher early viral loads. Neither Omicron BA.1 nor BA.5 replicated in brains, unlike most prior VOC. Only Omicron BA.5-infected mice exhibited substantial weight loss, high pathology scores in lungs, and high levels of inflammatory cells and cytokines in bronchoalveolar lavage fluid, and 5- to 8-month-old mice exhibited 100% fatality. These results identify a rodent model for pathogenesis or antiviral countermeasure studies for circulating SARS-CoV-2 Omicron BA.5. Further, differences in morbidity and mortality between Omicron BA.1 and BA.5 provide a model for understanding viral determinants of pathogenicity.